D-0288-2015 Class III Terminated
FDA drug recall D-0288-2015 was initiated by Sandoz, Inc on Oct 2, 2014 and is designated Class III. Reason for recall: Failed Impurities/Degradation Specifications: An Out of Specification (OOS) result was generated for the 18 month stability time point for ketone cilexetil impurity and total impurities. The recall status is terminated (terminated Jul 23, 2015). Affected quantity: 6,336 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Dec 10, 2014
- Initiation Date
- Oct 2, 2014
- Termination Date
- Jul 23, 2015
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 6,336 bottles
Product description
candesartan cilexetil, tablets, 16 mg, 90-count bottles, Rx only, Manufactured for Sandoz Inc., Princeton, NJ 08540 by Mylan Laboratories Limited Hyderabad, 500 034, India, NDC 0781-5938-92
Reason for recall
Failed Impurities/Degradation Specifications: An Out of Specification (OOS) result was generated for the 18 month stability time point for ketone cilexetil impurity and total impurities.
Distribution pattern
Nationwide
Code information
Lot #: 3007330, Exp 11/2014
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0288-2015
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026